跳至主要内容
临床试验/DRKS00021468
DRKS00021468已完成不适用

Exploring immunological control mechanisms of SARS-CoV-2 (COVID-19) - EIKOS

Institut für Virologie Uniklinik Köln0 个研究点目标入组 710 人开始时间: 2020年6月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
710

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • General inclusion criteria
  • - Age =18 years
  • - In generally good physical condition (Karnofsky-Index =80%)
  • Additional inclusion criterion when a cumulative blood volume of >100 ml is planned to be drawn:
  • - Current or previous laboratory-confirmed SARS-CoV-2 infection

排除标准

  • Exclusion criteria when a cumulative blood volume of >100 ml is planned to be drawn:
  • - Hemoglobin <10 g/dl
  • - Symptomatic cardiac disease (e.g., congestive heart failure NYHA =II, coronary artery disease)
  • - History of myocardial infarction
  • - COPD GOLD grade III-IV
  • - Body weight <45 kg (for a blood draw of =250 mL, a minimum body weight of 50 kg is required)
  • - <8 weeks (men) or <12 weeks (women) since last draw of a blood volume of =500 ml

研究者

发起方
Institut für Virologie Uniklinik Köln

相似试验